Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| SVP and Controller | Holzer Phil M | Aug 25, 2026 | Sell | $33.75K | 500 |
| CFO | Elkins David V | Apr 1, 2026 | Sell | $1.57M | 25,519 |
| CFO | Elkins David V | Apr 1, 2026 | Sell | $278.05K | 4,481 |
| CFO | Elkins David V | Sep 2, 2025 | Sell | $2.65M | 56,000 |
| EVP, Corporate Affairs | Short Bartie Wendy | Aug 2, 2025 | Sell | $16.72K | 378 |
| President | Hickey Benjamin | May 9, 2025 | Sell | $3.7K | 97.391 |
| EVP,Chief Med.Offr.,Drug Dev. | Hirawat Samit | Apr 25, 2025 | Buy | $202.22K | 4,250 |
| CEO | BOERNER CHRISTOPHER S. | Feb 20, 2025 | Buy | $110.1K | 2,000 |
| EVP,Chief Med.Offr.,Drug Dev. | Hirawat Samit | Feb 14, 2025 | Buy | $100K | 1,823.486 |
| SVP and Controller | Holzer Phil M | Nov 4, 2024 | Sell | $38.93K | 700 |
| EVP,Chief Med.Offr.,Drug Dev. | Hirawat Samit | Nov 1, 2024 | Buy | $100.06K | 1,830 |
| CEO | BOERNER CHRISTOPHER S. | Dec 5, 2023 | Buy | $99.56K | 2,000 |
| CEO | BOERNER CHRISTOPHER S. | Nov 28, 2023 | Buy | $150.05K | 3,071 |
| Director | Samuels Theodore R. II | Nov 20, 2023 | Buy | $423.39K | 8,500 |
| EVP, Chief Human Resources | Powell Ann | Aug 24, 2023 | Sell | $1.1M | 17,986 |
| EVP, Chief Research Officer | Plenge Robert M | Aug 3, 2023 | Sell | $44.75K | 732 |
| EVP & President, Research | Vessey Rupert | May 3, 2023 | Sell | $3.38M | 50,385 |
| CEO | Caforio Giovanni | Feb 6, 2023 | Sell | $17.92M | 240,000 |
| EVP, Chief Human Resources | Powell Ann | Feb 6, 2023 | Sell | $835.26K | 11,183 |
| EVP, Chief Human Resources | Powell Ann | Nov 9, 2022 | Sell | $1.31M | 16,250 |
| EVP, Research & Early Dev. | Vessey Rupert | Nov 7, 2022 | Sell | $3.62M | 45,910 |
| CEO | Caforio Giovanni | Sep 20, 2022 | Sell | $1.74M | 25,000 |
| CEO | Caforio Giovanni | Sep 15, 2022 | Sell | $3.59M | 50,000 |
| EVP, Chief Human Resources | Powell Ann | Sep 14, 2022 | Sell | $1.77M | 25,000 |
| CFO | Elkins David V | Sep 13, 2022 | Sell | $2.14M | 30,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
